I****a 发帖数: 407 | 1 “Prostate cancer is a serious health problem that affects thousands of men
and their families. But before getting a PSA test, all men deserve to know
what the science tells us about PSA screening: there is a very small
potential benefit and significant potential harms. We encourage clinicians
to consider this evidence and not screen their patients with a PSA test
unless the individual being screened understands what is known about PSA
screening and makes the personal decision that even a small possibility of
benefit outweighs the known risk of harms.”
—USPSTF Co-Chair Michael LeFevre, M.D., M.S.P.H.
May 22, 2012 | A*******s 发帖数: 9638 | | C*****D 发帖数: 1299 | 3 USPSTF alway has some surprise recommendations. 2 years ago, the mammograph
recomendation, which draw huge criticism from radiologists
This time, the fight is far from over, as it touched the cheese of
urologists.
Next time, will be PAP smear, then the OB/GYN, primary care and
cytopathology will be affected.
All the recommedations are non-bound, till HHS secretory sign the bill.
From the population study and financial reasons, PSA might not be a good
test, but what the replacement?
if PSA screening is removed from the prevention list, most patients have to
pay out of the packet (part of recent insurance deductable movement). The
insurance compay will be happier. Many GU commerical labs will suffer.
Wait and see if Obama goverment will push for it.
http://www.auanet.org/content/health-policy/government-relation | A*******s 发帖数: 9638 | 4 Most GU pathologist would suffer as well, lol
觉得心术里说的“度”很重要, 全民保险, 全民器官移植, 全国破产,其实道理真
的很简单。
民主党要全民保险想的是选票, 共和党反对是因为钱的问题。 自由平等还是社会责任
, 我觉得还是共和党靠谱。
if PSA screening is removed from the prevention list, most patients have to
pay out of the packet (part of recent insurance deductable movement). The
insurance compay will be happier. Many GU commerical labs will suffer.
【在 C*****D 的大作中提到】![](/moin_static193/solenoid/img/up.png) : USPSTF alway has some surprise recommendations. 2 years ago, the mammograph : recomendation, which draw huge criticism from radiologists : This time, the fight is far from over, as it touched the cheese of : urologists. : Next time, will be PAP smear, then the OB/GYN, primary care and : cytopathology will be affected. : All the recommedations are non-bound, till HHS secretory sign the bill. : From the population study and financial reasons, PSA might not be a good : test, but what the replacement? : if PSA screening is removed from the prevention list, most patients have to
| C*****D 发帖数: 1299 | 5 现在是民主党提的。有些screen用处确实不大。GU的prostate biopsy 是大头, 不做
后,urologist收入会影响很大。看来还是PC保险。
几个月前我就贴过个不要选GU path 的贴,马上cyto也会suffer。 只有derm和GI现在
没见有近期变化。
to
【在 A*******s 的大作中提到】![](/moin_static193/solenoid/img/up.png) : Most GU pathologist would suffer as well, lol : 觉得心术里说的“度”很重要, 全民保险, 全民器官移植, 全国破产,其实道理真 : 的很简单。 : 民主党要全民保险想的是选票, 共和党反对是因为钱的问题。 自由平等还是社会责任 : , 我觉得还是共和党靠谱。 : : if PSA screening is removed from the prevention list, most patients have to : pay out of the packet (part of recent insurance deductable movement). The : insurance compay will be happier. Many GU commerical labs will suffer.
| I****a 发帖数: 407 | 6 I remembered that Pap smear now is very 3 years, updated just recently. | C*****D 发帖数: 1299 | 7 是。所以现在PAP SMEAR 标本量开始大幅减少。cytotech 已很难找工作了。
【在 I****a 的大作中提到】![](/moin_static193/solenoid/img/up.png) : I remembered that Pap smear now is very 3 years, updated just recently.
| u*******2 发帖数: 287 | 8 *************“If your income is dependent on you not understanding
something, it is very easy not to understand something.”***********
LOL
Originally Posted by NYT
“All of us take extraordinary issue with both the methodology and
conclusion of that report,” said Dr. Deepak Kapoor, chairman and chief
executive of Integrated Medical Professionals, a group that includes the
nation’s largest urology practice. “We will not allow patients to die,
which is what will happen if this recommendation is accepted.” He and other
urologists said that the P.S.A. test is just one part of an overall
strategy that, in the hands of well-trained doctors, can help prevent death
and other consequences of cancer.
Treating patients with prostate cancer is a highly profitable business in
the United States, and much of the practice of urology is dedicated to this
fight. If men no longer get screened routinely, urologists will see a steep
decline in patient visits and income. But Dr. Kapoor rejected the notion
that profit plays any role in his defense of screening.
“That I’m going to treat patients that don’t need therapy is morally
repugnant,” he said.
But Dr. Otis Brawley, chief medical officer of the American Cancer Society,
suggested that is what doctors like Dr. Kapoor are doing. “We in medicine
need to look into our soul and we need to learn the truth,” he said.“If your income is dependent on you not understanding
something, it is very easy not to understand something.” |
|